Published in Medical Devices and Surgical Technology Week, January 15th, 2006
This change in auditors was approved by the Audit Committee of the company's board of directors.
The decision was not the result of any disagreement between the company and Ernst & Young LLP on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure.
Immucor manufactures and sells a line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.